UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - NYSE:UHS - US9139031002 - Common Stock
226.29 USD
-0.21 (-0.09%)
Taking everything into account, UHS scores 6 out of 10 in our fundamental rating. UHS was compared to 100 industry peers in the Health Care Providers & Services industry. While UHS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UHS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year UHS was profitable.
UHS had a positive operating cash flow in the past year.
UHS had positive earnings in each of the past 5 years.
UHS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of UHS (8.96%) is better than 94.00% of its industry peers.
UHS's Return On Equity of 19.18% is amongst the best of the industry. UHS outperforms 86.00% of its industry peers.
The Return On Invested Capital of UHS (12.33%) is better than 88.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 9.40%.
The last Return On Invested Capital (12.33%) for UHS is above the 3 year average (8.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROIC | 12.33% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
With an excellent Profit Margin value of 8.09%, UHS belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
UHS has a better Operating Margin (11.47%) than 80.00% of its industry peers.
UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, UHS has less shares outstanding
UHS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for UHS has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of UHS is 4.84, which is a neutral value as it means it would take UHS, 4.84 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.84, UHS is in the better half of the industry, outperforming 67.00% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
UHS has a Debt to Equity ratio (0.55) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | N/A |
ROIC/WACC1.46
WACC8.46%
2.3 Liquidity
UHS has a Current Ratio of 1.03. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
UHS has a worse Current ratio (1.03) than 72.00% of its industry peers.
UHS has a Quick Ratio of 1.03. This is a bad value and indicates that UHS is not financially healthy enough and could expect problems in meeting its short term obligations.
UHS has a Quick ratio of 0.96. This is in the lower half of the industry: UHS underperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.07%, which is quite impressive.
The Earnings Per Share has been growing by 10.74% on average over the past years. This is quite good.
The Revenue has grown by 10.21% in the past year. This is quite good.
UHS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.53% yearly.
UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
UHS is valuated reasonably with a Price/Earnings ratio of 10.88.
UHS's Price/Earnings ratio is rather cheap when compared to the industry. UHS is cheaper than 89.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.56, UHS is valued rather cheaply.
UHS is valuated reasonably with a Price/Forward Earnings ratio of 9.71.
Based on the Price/Forward Earnings ratio, UHS is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.62, UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.88 | ||
| Fwd PE | 9.71 |
4.2 Price Multiples
UHS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UHS is cheaper than 82.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.87 | ||
| EV/EBITDA | 7.44 |
4.3 Compensation for Growth
UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UHS may justify a higher PE ratio.
UHS's earnings are expected to grow with 15.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)1.01
EPS Next 2Y18.34%
EPS Next 3Y15.88%
5. Dividend
5.1 Amount
With a yearly dividend of 0.35%, UHS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.57, UHS pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.35, UHS pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
5.2 History
On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
UHS has paid a dividend for at least 10 years, which is a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
UHS pays out 3.78% of its income as dividend. This is a sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
NYSE:UHS (11/18/2025, 10:12:01 AM)
226.29
-0.21 (-0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.12%
Inst Owner Change-2.36%
Ins Owners5.45%
Ins Owner Change16.08%
Market Cap14.40B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts70.77
Price Target231.73 (2.4%)
Short Float %3.44%
Short Ratio2.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)4.41%
PT rev (3m)2.74%
EPS NQ rev (1m)4.94%
EPS NQ rev (3m)4.66%
EPS NY rev (1m)3.24%
EPS NY rev (3m)7.7%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.88 | ||
| Fwd PE | 9.71 | ||
| P/S | 0.85 | ||
| P/FCF | 14.87 | ||
| P/OCF | 7.39 | ||
| P/B | 2.01 | ||
| P/tB | 4.53 | ||
| EV/EBITDA | 7.44 |
EPS(TTM)20.8
EY9.19%
EPS(NY)23.3
Fwd EY10.3%
FCF(TTM)15.21
FCFY6.72%
OCF(TTM)30.61
OCFY13.53%
SpS267.01
BVpS112.66
TBVpS49.97
PEG (NY)0.38
PEG (5Y)1.01
Graham Number229.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROCE | 16% | ||
| ROIC | 12.33% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 18.59% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A | ||
| FCFM | 5.7% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 162.72% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 15.36 | ||
| Cash Conversion | 76.35% | ||
| Profit Quality | 70.41% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | N/A |
F-Score8
WACC8.46%
ROIC/WACC1.46
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year55.52%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
What is the valuation status for UHS stock?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for UHS stock?
The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 10.88 and the Price/Book (PB) ratio is 2.01.
Can you provide the financial health for UHS stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 4 / 10.